155 related articles for article (PubMed ID: 21781150)
1. Acute hepatic injury following treatment of a long-acting insulin analogue overdose necessitating urgent insulin depot excision.
Warriner D; Debono M; Gandhi RA; Chong E; Creagh F
Diabet Med; 2012 Feb; 29(2):232-5. PubMed ID: 21781150
[TBL] [Abstract][Full Text] [Related]
2. Problem based review: the patient who has taken an overdose of long-acting insulin analogue.
Eldred AE; Mustafa OG; Hunt KF; Whitelaw BC
Acute Med; 2013; 12(3):167-72. PubMed ID: 24098877
[TBL] [Abstract][Full Text] [Related]
3. Early hypoglycaemia after accidental intramuscular injection of insulin glargine.
Karges B; Boehm BO; Karges W
Diabet Med; 2005 Oct; 22(10):1444-5. PubMed ID: 16176210
[TBL] [Abstract][Full Text] [Related]
4. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
5. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
Groth CM; Banzon ER
J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
[TBL] [Abstract][Full Text] [Related]
6. Lantus insulin overdose: a case report.
Lu M; Inboriboon PC
J Emerg Med; 2011 Oct; 41(4):374-7. PubMed ID: 20493654
[TBL] [Abstract][Full Text] [Related]
7. Prolonged glucose requirements after intentional glargine and aspart overdose.
Fromont I; Benhaim D; Ottomani A; Valéro R; Molines L; Vialettes B
Diabetes Metab; 2007 Nov; 33(5):390-2. PubMed ID: 17644447
[TBL] [Abstract][Full Text] [Related]
8. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
9. Insulin glargine: a long-acting insulin for diabetes mellitus.
Garces K
Issues Emerg Health Technol; 2003 Nov; (52):1-4. PubMed ID: 14626260
[TBL] [Abstract][Full Text] [Related]
10. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
12. [Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].
Arzumetova DS; Saburenko MB; Shagazatova BKh; Zabikhodzhaeva GZ
Klin Med (Mosk); 1989 Apr; 67(4):99-101. PubMed ID: 2666739
[TBL] [Abstract][Full Text] [Related]
13. Insulin glargine for type 2 diabetes.
Hemraj F; Garces K
Issues Emerg Health Technol; 2004 Aug; (59):1-4. PubMed ID: 15311441
[TBL] [Abstract][Full Text] [Related]
14. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
Tan CY; Wilson DM; Buckingham B
Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
[TBL] [Abstract][Full Text] [Related]
15. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
[TBL] [Abstract][Full Text] [Related]
16. [Clinical use of long-acting insulin analogs].
Birkeland KI
Tidsskr Nor Laegeforen; 2006 Apr; 126(8):1067-8. PubMed ID: 16619068
[No Abstract] [Full Text] [Related]
17. [Diabetes mellitus type II: when convert to insulin?].
Bianda TL; Spinas GA
Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycemia rates with basal insulin analogs.
Little S; Shaw J; Home P
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S53-64. PubMed ID: 21668338
[TBL] [Abstract][Full Text] [Related]
19. Glucose or intermittent high-intensity exercise in glargine/glulisine users with T1DM.
Dubé MC; Lavoie C; Weisnagel SJ
Med Sci Sports Exerc; 2013 Jan; 45(1):3-7. PubMed ID: 22895370
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.
Bolli GB; Andreoli AM; Lucidi P
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S43-52. PubMed ID: 21668336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
